Home › Funds › SALT Holding Corp. › GSK
SALT Holding Corp. position in GSK
GSK PLC · Health Care
SALT Holding Corp. reported holding 235,459 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 6.54% of its reported portfolio and ranking #6 among its reported holdings. SALT Holding Corp. has disclosed GSK holdings in 3 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SALT Holding Corp.'s GSK position evolved
SALT Holding Corp. first disclosed a stake in GSK in Q4 2024 at 61,612 shares (US$2.1M). The position peaked in Q2 2026 at 235,459 shares, worth US$12.3M. Across 3 filings, SALT Holding Corp. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 235,459 shares valued at US$12.3M. Notable position changes include a 47% increase in Q1 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 61.61K | $2.08M | New |
| Q1 2025 | 90.66K | $3.51M | Add |
| Q2 2026 | 235.46K | $12.34M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on SALT Holding Corp.
FAQ
How long has SALT Holding Corp. held GSK?
SALT Holding Corp. has disclosed GSK holdings in 3 of the last 7 reported quarters, going back to Q4 2024.
What is SALT Holding Corp.'s current position in GSK?
As of Q2 2026, SALT Holding Corp. holds 235.46K shares of GSK (GSK PLC), valued at $12.34M, representing 6.54% of its reported portfolio and ranking #6.
Has SALT Holding Corp. been buying or selling GSK?
In the latest 13F filing (Q2 2026), SALT Holding Corp. newly opened its position in GSK. The position peaked in Q2 2026 at 235.46K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.